Posters
« Back
Repurposing Drugs for the Treatment of Multi-Drug Resistant Breast Cancer
EP20244
Poster Title: Repurposing Drugs for the Treatment of Multi-Drug Resistant Breast Cancer
Submitted on 19 Dec 2013
Author(s): David Monaghan, Rachel Griffin, Amie Regan, Enda O’Connell, Howard Fearnhead
Affiliations: National University of Ireland, Galway
Poster Views: 1,548
View poster »


Poster Information
Abstract: In this study, the Johns Hopkins Clinical Compound Library, containing approximately 1,500 FDA and foreign-approved clinical compounds, was used to screen a multi-drug resistant, triple negative breast cancer cell line for drug sensitivity.Summary: In this study, the Johns Hopkins Clinical Compound Library, containing approximately 1,500 FDA and foreign-approved clinical compounds, was used to screen a multi-drug resistant, triple negative breast cancer cell line for drug sensitivity.Report abuse »
Creative Commons

Related Posters


Delivery of RNP complexes for CRISPRi (dCas9) silencing in vitro and in vivo using crystalline ultrasmall particles (CUSP)
GM Unger*, VL Korman, BT Kren, DL Tobolt

Genetic Engineering in Male Sterility for Hybrid Variety Development
Abir Hasan Joy

Platinum™ II Taq Hot-Start DNA Polymerase: PCR simplified with universal annealing
Skaistė Valinskytė, Edita Elijošiūtė, Tomas Radzvilavičius, Miglė Mikutėnaitė, Jonas Belevičius, Aistė Serapinaitė, Rasa Sukackaitė

Single-use technology in the production of DNA-free Taq DNA polymerase
Kęstutis Bargaila, Vytautas, Budrys, Andrius Krasauskas, Dovilė Lisauskienė, Milda Romeikaitė, Sonata J.-Urbanavičienė, and Juozas Šiurkus

Lyo-ready SuperScript Reverse Transcriptases: High-Performance Lyophilization-Compatible Enzymes for RT-PCR-based assays
Inga Šerėnaitė, Darius Kavaliauskas, Monika Raižytė, Viktorija Urbonė, Gitana Timofejevaitė, Andrejus Naumovas, Juozas Šiurkus. Thermo Fisher Scientific Baltics UAB, V. A. Graičiūno 8, Vilnius, Lithuania